Connect with us

Health

Johnson & Johnson stop production of Covid-19 vaccine; what it may signal

Published

on

By Dana Malcolm

Staff Writer

 

February 16, 2022 – Johnson & Johnson has officially halted production at all of its Covid-19 vaccine producing facilities; this comes after last week’s announcement that some production would be stopped for the pharmaceutical company to shift focus to a new vaccine, unrelated to Covid-19.

The move comes as vaccination drives slow in higher income countries especially those in Europe and they begin to cancel Covid-19 restrictions.

Johnson & Johnson said, “We strive to improve human health and have worked tirelessly to … build a global manufacturing network across four continents to produce our COVID-19 vaccine. Our manufacturing sites produce multiple products as we have an obligation to supply life changing medicines to patients around the world and bring forward our innovative pipeline of new medicines and vaccines. We manage our production planning accordingly and are currently supplying from our extensive global network based on the demand for our vaccine and the needs of our patients and customers.”

The pharmaceutical company announced on February 8 that the plant would cease COVID19 operations temporarily to work on another vaccine for a different virus The New York Times reports.

The move prompted immediate fears from organizations like COVAX  and the African Union which depends on the Johnson & Johnson vaccine to meet their quotas and distribute the vaccines to poorer countries worldwide.

Despite the controversy surrounding the vaccine and its effects in relation to blood clotting Johnson & Johnson has been one of the most distributed brands in the world.

The company has said that they supply based on the needs of patients and customers but only 54 per cent of the world has been fully vaccinated against COVID-19 so far. Notable is the staggering unevenness of the vaccination: only 11 per cent of the population has received one dose of a vaccine in low income countries.  Conversely, high income countries have successfully vaccinated over 78 per cent of their populations.

Johnson & Johnson is currently in use in 82 different countries worldwide.

This begs the question of why Johnson & Johnson is stopping production when there are so many persons in lower income countries especially still depending on its vaccine

The NY Times also reports that neither COVAX or The African Union were informed of the decision by Johnson & Johnson beforehand.

The African Union said, “This is not the time to be switching production lines of anything, when the lives of people across the developing world hang in the balance.”

COVAX expressed similar sentiments. They said that Johnson & Johnson had already let them down in 2021 and they couldn’t of the word to be let down in 2022.

In response J&J said “We are focused on ensuring our vaccine is available where people are in need, and we continue to fulfill our contractual obligations in relation to the COVAX Facility and the African Union, we currently have millions of doses of our COVID-19 vaccine in inventory.”

Johnson & Johnson struggled with vaccines expiring before they were able to be used early in production. The FDA extended the expiry dates in July last year from the initial four and a half months.

The vaccines currently have a shelf life of six months.

Health

Measles Alert, Ministry of Health concerned about Patients

Published

on

The Ministry of Health and Human Services is asking all clients seen at the Cheshire Hall Medical Center Emergency Department on April 21, 2024, April 22, 2024, and May 3, 2024, to remain vigilant for any signs and symptoms of Measles. Any signs and symptoms noted must be reported immediately to your doctor.

As a reminder, the signs and symptoms of measles are:

  • Fever
  • Red rash (starts behind the ear and then spreads to the head and neck then body)
  • Coryza (runny nose)
  • Cough
  • Conjunctivitis (red eyes)
  • Body aches

Small greyish-white spots with a bluish-white center inside the mouth, cheek, and throat.

Measles is highly infectious and can be spread quickly in persons who are unvaccinated. If you think that you have been in contact with someone with symptoms of measles, please do not hesitate to see your doctor. For more information please call (649) 338-5469. For further information please visit the Ministry of Health and Human Services Facebook page at https://www.facebook.com/tciministryofhealth/.

 

 

 

 

Continue Reading

Caribbean News

Belize, Jamaica and St. Vincent and the Grenadines eliminate mother-to-child transmission of HIV and Syphilis 

Published

on

Belize, Jamaica, and St. Vincent and the Grenadines are the latest countries in the Americas to receive certification from the World Health Organization (WHO) for eliminating the mother-to-child transmission of HIV and syphilis (EMTCT). The milestone was marked today at a commemorative event organized by the Pan American Health Organization (PAHO) in Kingston, Jamaica, with support from UNICEF and UNAIDS and with the participation of health ministers from the three countries.

 

“This achievement is a testament to years of dedication, hard work, and collaboration among governments, health professionals, and communities”, PAHO Director Dr. Jarbas Barbosa said at the event. Dr. Barbosa also acknowledged the “remarkable resilience” displayed by the three countries, ensuring the adaptation and continuation of essential services despite the challenges posed by the COVID-19 pandemic. “I trust that the celebration today will inspire other countries to reinvigorate their commitments” towards a generation free of HIV and congenital syphilis.

 

In 2010, countries of the Americas committed to the elimination of mother-to-child transmission of HIV and syphilis and endorsed the regional strategy, which was updated in 2016 under the PAHO Plan of Action for the Prevention and Control of HIV and Sexually Transmitted Infections.

 

To meet elimination targets, countries focused on strengthening prevention and treatment services within primary health care and in maternal and child health, updating guidelines, ensuring the effective screening of pregnant women, monitoring cases and following-up with HIV and syphilis exposed infants.

 

In a video message, WHO Director-General Dr. Tedros Adhanom Ghebreyesus, praised Belize for integrating primary disease prevention and treatment into maternal and child health services. He also commended Jamaica for its civil society organizations’ commitment to human rights and lauded St. Vincent and the Grenadines for investing in robust national laboratory structures. “While validation is a tremendous accomplishment, maintaining it requires sustained efforts to prevent new infections,” he said. “WHO and partners will continue to support all countries in the Americas to strengthen health systems, provide comprehensive services, and ensure the involvement of women in planning and service delivery.”

 

Globally, 19 countries and territories have now been certified for eliminating mother-to-child transmission of HIV and/or syphilis, with 11 of them located in the Americas. In 2015, Cuba made history by becoming the first country in the world to achieve the dual elimination of HIV and syphilis. This was followed by Anguilla, Antigua and Barbuda, Bermuda, Cayman Islands and Montserrat and St. Kitts and Nevis in 2017, and Dominica in 2020.

 

“The end of AIDS is an opportunity for a uniquely powerful legacy for today’s leaders. We are again celebrating a great public health milestone today as Caribbean countries show global leadership in the elimination agenda to achieve an HIV free generation,” Christine Stegling, UNAIDS Deputy Executive Director, said.

 

New HIV infections among children in the Caribbean decreased by 25% between 2010 and 2022. During that period, annual notified cases declined from 2,000 to 1,500. Reported cases of congenital syphilis in the English-speaking Caribbean now stand at 36 cases per 100,000 newborns, below the goal of no more than 50 cases per 100,000 newborns.

 

“UNICEF welcomes the commitment of Belize, Jamaica and Saint Vincent and the Grenadines for achieving the double elimination of vertical transmission for HIV and Syphilis”, Garry Conille, UNICEF Regional Director for Latin America and the Caribbean, said. “We are confident that this milestone will be a catalyst for other countries in the region to pursue the Elimination of Mother-to-Child Transmission Agenda toward the 2030 target: No child left behind in the progress to end AIDS,” Conille added.

 

WHO awards this certification to countries which have brought the mother-to-child HIV transmission rate to under 5%; provided antenatal care and antiretroviral treatment to more than 90% of pregnant women; reported fewer than 50 new cases of congenital syphilis per 100,000 newborns, and achieved an HIV case rate of fewer than 500 per 100,000 live births.

 

Elimination Initiative

 

The PAHO Elimination Initiative seeks to put an end to more than 30 communicable diseases, including the mother-to-child transmission of HIV and syphilis, in Latin America and the Caribbean by 2030.

 

The initiative was relaunched during the Organization’s 60th Directing Council and seeks to harness the lessons learned from the COVID-19 pandemic, as well as from previous elimination experiences to accelerate disease elimination in the Region.

 

Quotes from Ministers of Health

 

Kevin Bernard, Minister of Health and Wellness of Belize: “Eliminating mother to child transmission of HIV and syphilis is an extremely significant accomplishment for the people and the country of Belize. The activities leading up to this momentous goal were not always easy, however with the commitment and motivation of our health care workers, in all areas of health, this has become a reality. We continue to work towards achieving public health goals for a healthier and more productive Belize.”

 

Dr. Christopher Tufton, Minister of Health and Wellness of Jamaica: “The elimination of mother-to-child transmission of HIV and syphilis is a win that underscores protecting the health of all. It is also exemplary of the extraordinary progress being made in our maternal health care. What’s more, it is vitally important that we consolidate the gains made from this achievement, especially through continued community engagement and partnership in the public health interest of all.”

 

St. Clair Jimmy Prince, Minister of Health, Wellness and the Environment of St Vincent and the Grenadines: “I commend the dedication and commitment of healthcare workers on achieving certification by the World Health Organization (WHO) of the dual elimination of mother to child transmission (EMTCT) of HIV and syphilis. This achievement signals to the world that ending paediatric HIV and congenital syphilis through the elimination of mother to child transmission of HIV and syphilis is achievable. The Ministry will continue to work towards ending AIDS as a public health threat by 2030.”

 

Continue Reading

Health

Ministry of Health and Human Services Confirm Two Measles Cases 

Published

on

Grand Turk, Turks and Caicos Islands – 11th May 2024: On Thursday, 9th May 2024, results of testing for two suspected measles cases were received from the Caribbean Public Health Agency, confirming that both cases were positive for measles. These represent the first cases of measles in the TCI since 1991.

The public health team has been responding since initial reports of the suspected cases, carrying out contact tracing, isolation, public education and outreach in anticipation of yesterday’s results. No additional suspected cases have been identified at this time. All unvaccinated contacts of the confirmed cases have been vaccinated. Additional vaccination efforts will be conducted throughout the TCI.

The public health team has been receiving technical support from its key stakeholders including the Caribbean Public Health Agency (CARPHA), UK Health Security Agency (UKHSA) and Pan American Health Organisation (PAHO).

Measles is a highly infectious disease caused by a virus that spreads easily between people. Symptoms typically start between 10 and 12 days after catching the infection. The signs and symptoms of measles are:

  • A high fever
  • Runny or blocked nose
  • Cough
  • Red, sore, watery eyes

Small greyish-white spots with a bluish-white center inside the mouth, cheek, and throat may appear a few days later. A rash usually appears 2-4 days after the cold-like symptoms start. The rash starts on the face and behind the ears before spreading to the rest of the body.

Measles is spread through close contact with someone with measles. This could be through droplets in the air which are generated by the coughs and sneezes of infected persons or by touching things that someone with measles has coughed or sneezed on.

Measles spreads easily within households and in other places where people mix closely together. Measles is so contagious that if one person has it, up to 90% of the people close to that person who are not immune will also become infected. The period when a person is infectious and can spread the virus is within 7 to 10 days of exposure but can be up to 14 days.

Most measles-related deaths are caused by complications associated with the disease and serious complications are more common in children under the age of 5, or adults over the age of 30 and individuals whose immune systems have been weakened. The most serious complications include blindness, encephalitis (an infection that causes brain swelling), severe diarrhoea and related dehydration, ear infections, or severe respiratory infections such as pneumonia. Women infected while pregnant are also at risk of severe complications, and the pregnancy may end in miscarriage or preterm delivery. People who recover from measles are immune for the rest of their lives.

Any non-immune person (who has not been vaccinated or was vaccinated but did not develop immunity) can become infected.

No specific antiviral treatment exists for measles virus.
Severe complications from measles can be avoided through supportive care that ensures good nutrition, adequate fluid intake and treatment of dehydration with WHO-recommended oral rehydration solution. This solution replaces fluids and other essential elements that are lost through diarrhoea or vomiting. Antibiotics should be prescribed to treat eye and ear infections, and pneumonia.

A number of measles outbreaks have been detected globally and regionally. While the TCI has high vaccination coverage in the measles, mumps and rubella vaccine (MMR) (>95%), unvaccinated persons can still acquire measles through contact with an infectious person.

Having the MMR vaccine is the best way to prevent measles. The vaccine is safe and effective in providing long term protection against measles, mumps and rubella. Vaccines are offered free of cost to all children at government-operated primary care facilities across the TCI.

The Ministry of Health and Human Services encourages parents to ensure that their children’s vaccines are up to date.  If you are unsure if you or your child has had 2 doses of the MMR vaccine, please visit your health care provider. If you have missed a dose, you can still be vaccinated at any age.

The public is being advised to remain vigilant and report any fever with rash or fever followed by rash to their doctor/health care provider as soon as possible.

The Ministry of Health and Human Services is grateful for the support of its stakeholders, including CARPHA, who provided the results of testing in such a prompt manner.
The Ministry of Health and Human Services will continue heightened surveillance for fever and rash and take necessary actions to mitigate against further cases.

For additional information please call 649-338-5469 or visit the Ministry of Health and Human Services Facebook page at https://www.facebook.com/tciministryofhealth/.

Continue Reading

FIND US ON FACEBOOK

TRENDING